A 'walk through time' as GSK prepares to exit Boronia production site

The third part in a series to mark GSK's exit from its Boronia facility is focused on the history of its more than five decades at a site that ultimately become its largest manufacturing facility in the southern hemisphere, producing over 500 million doses each year that were exported to almost 60 countries. …